News Focus
News Focus
Followers 60
Posts 11382
Boards Moderated 0
Alias Born 01/31/2008

Re: mrplmer post# 350793

Friday, 02/11/2022 10:22:43 AM

Friday, February 11, 2022 10:22:43 AM

Post# of 517673
So we believe we woke up to be the voice of reason today. How fortunate for us. My argument will remain valid.

Just not nearly as valid as mine.

Dr. M is getting the trials done and moving the drug to approval.

Dr. M is doing this with minimal dilution.

In the end, getting 273 on the market is all that matters.

Dr. M's PR limitations can be dealt with by hiring a better PR firm.

There is little likelihood that a new CEO would be better than Dr. M.

Anyone with substantial biotech experience knows Dr. M is better than 90% of small biotech CEOs. Claiming otherwise is BS.




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News